Login / Signup

Hematopoietic cell transplantation for myeloid/NK cell precursor acute leukemia in second remission.

Yusuke NoguchiDaisuke TomizawaHaruka HirokiSatoshi MiyamotoMari TezukaReiji MiyawakiMari Tanaka-KubotaTubasa OkanoChika KobayashiNoriko MitsuikiYuki AokiKohsuke ImaiMichiko KajiwaraHirokazu KaneganeTomohiro MorioMasatoshi Takagi
Published in: Clinical case reports (2018)
Myeloid/natural killer cell precursor acute leukemia (MNKPL) is a rare leukemia subtype characterized by a high incidence of extramedullary infiltration. No appropriate treatment strategy has so far been developed. Acute myelogenous leukemia-type chemotherapy combined with L-Asparaginase is an effective treatment for MNKPL. Hematopoietic cell transplantation is a second option in refractory cases.
Keyphrases
  • bone marrow
  • acute myeloid leukemia
  • nk cells
  • dendritic cells
  • risk factors
  • liver failure
  • single cell
  • intensive care unit
  • hepatitis b virus
  • combination therapy
  • drug induced
  • rectal cancer
  • smoking cessation